Literature DB >> 1003430

Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin.

F Arcamone, S Penco, S Redaelli, S Hanessian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003430     DOI: 10.1021/jm00234a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  13 in total

Review 1.  Anthracycline analogs: the past, present, and future.

Authors:  R B Weiss; G Sarosy; K Clagett-Carr; M Russo; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.

Authors:  F Arcamone; L Bernardi; B Patelli; P Giardino; A Di Marco; A M Casazza; C Soranzo; G Pratesi
Journal:  Experientia       Date:  1978-10-15

3.  Phase I trial with 4'-deoxydoxorubicin (esorubicin).

Authors:  M Rozencweig; N Crespeigne; Y Kenis
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.

Authors:  W P McGuire; J A Blessing; M L Berman
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

5.  High incidence of local venous reactions to esorubicin.

Authors:  K M Lee; R T Dorr; A Robertone
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

6.  Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.

Authors:  J R Rigas; M G Kris; R J Gralla; R T Heelan; L D Marks
Journal:  Invest New Drugs       Date:  1991-05       Impact factor: 3.850

7.  Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.

Authors:  F Formelli; C Pollini; A M Casazza; A di Marco; A Mariani
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.

Authors:  A Bargiotti; A M Casazza; G Cassinelli; A Di Marco; S Penco; G Pratesi; R Supino; A Zaccara; F Zunino; F Arcamone
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Phase I trial of 4'-deoxydoxorubicin given weekly.

Authors:  C Sessa; L Bosia; S Kaplan; C Pusterla; M Varini; F Cavalli
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

10.  Phase I study with 4'-deoxydoxorubicin.

Authors:  L Ferrari; A Rossi; C Brambilla; V Bonfante; F Villani; F Crippa; G Bonadonna
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.